Discontinuation by "tapering" vs usual family planning care: Adverse events
It is very uncertain whether discontinuation by "tapering" changes adverse events compared with continuation (or usual care) (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Discontinuation by "tapering" vs continuation (or usual care) Adverse events · participants with depressive or anxiety disorders It is very uncertain whether discontinuation by "tapering" changes adverse events compared with continuation (or usual care) (very low certainty). Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and… (2021) · Cochrane Headline outcomes only | OR 1.06 [0.82, 1.38] | 7 studies · 1479 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults 2021 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.